Barinthus Biotherapeutics Cash Flow Statement (2020-2025) | BRNS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -4.65M-4.34M-2.40M-12.26M-8.76M-16.86M-5.53M-16.84M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Depreciation and Depletion 0.20M0.20M0.40M0.30M0.40M0.50M0.70M0.70M0.60M0.70M0.70M0.60M1.20M1.20M0.10M
Share-based Compensation 0.86M0.41M0.15M2.20M0.80M8.74M3.37M3.58M3.98M2.75M1.10M2.04M2.22M1.99M0.06M0.79M1.61M1.20M1.14M0.76M0.47M-0.28M-0.41M
Deferred Taxes -0.03M-0.01M-0.03M-0.06M-0.86M-0.92M-0.62M-1.93M-0.52M-1.14M-0.60M-0.82M-0.04M-0.01M-0.00M0.00M-0.02M-0.03M-0.07M
Gains from Sales and Divestitures 0.51M0.51M0.51M
Gains from Investment Securities 0.01M0.01M0.01M0.14M1.65M0.14M0.63M0.32M0.09M0.22M-0.22M-0.03M0.06M0.02M-0.38M1.17M0.00M-0.34M0.69M
Asset Writedowns and Impairment 2.60M4.67M
Non-cash Items 11.02M5.53M19.82M16.06M16.95M14.80M11.50M8.70M7.10M9.00M6.50M4.10M
Cash from Operations -4.32M-0.95M-0.86M-4.90M-7.97M-14.62M-2.02M-7.97M-6.58M-8.39M11.88M-11.34M-3.17M-16.96M-11.19M-19.60M-11.82M-12.01M-18.20M13.09M-14.90M-18.11M-10.73M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.05M0.05M0.06M0.06M0.09M0.10M0.09M0.32M0.97M0.99M1.19M1.18M1.22M1.30M1.47M1.44M1.43M1.47M1.48M1.43M2.03M2.00M0.90M
Change in Working Capital
Change in Receivables -0.52M0.08M-0.49M0.45M-0.21M-0.28M0.01M-0.07M18.35M-1.32M-10.87M-0.33M-4.96M-0.65M-0.19M
Change in Account Payables -1.15M-0.32M-0.55M2.60M-0.71M-0.84M-1.87M-0.11M1.74M-0.96M-0.63M1.00M-1.71M-0.21M2.33M-3.79M-0.52M1.49M0.39M-0.46M-1.16M0.34M-1.04M
Change in Accured Expenses 0.34M0.18M0.68M-0.17M-0.11M0.87M1.08M2.57M2.83M-3.32M5.55M-4.32M-1.31M1.59M4.96M-3.24M-0.82M1.96M-2.67M1.98M-2.52M-0.24M-0.57M
Other Working Capital Changes -0.17M0.03M1.00M-0.43M0.39M6.78M-1.68M-1.27M1.12M4.90M-3.07M-0.78M-4.09M0.98M-2.14M3.05M-1.88M2.71M-2.92M-1.56M-0.48M-0.49M-0.50M
Investing Activities
Capital Expenditures 0.02M1.48M-1.40M0.20M0.39M0.20M0.13M0.42M1.36M1.78M2.41M0.59M2.51M3.02M0.04M-0.15M0.31M0.19M0.11M0.28M0.01M0.03M
Cash from Investing Activities -0.02M-0.05M-0.03M-0.20M-0.39M-0.20M-0.13M-12.19M-1.09M-2.05M-2.02M-0.59M-2.51M-3.02M-0.04M0.15M-0.31M-0.19M-0.11M-0.28M-0.01M-0.03M0.45M
Financing Activities
Other financing activities 0.04M0.02M0.76M1.39M
Cash from Financing Activities 16.48M121.81M102.31M-1.39M0.01M-0.16M0.48M1.69M0.03M0.05M0.11M0.50M0.36M0.47M0.84M0.00M
Additional items
Exchange Rate Effect -0.66M-0.16M0.29M2.25M-0.79M0.20M-6.21M0.34M-5.63M2.18M-2.09M5.73M0.94M1.65M-1.54M1.12M-0.49M-0.36M6.17M-7.35M3.08M5.35M-1.83M
Change in Cash -5.00M-1.16M24.35M13.64M112.67M87.68M-9.75M-19.82M-13.46M-8.27M7.78M-5.72M-3.06M-18.30M-12.72M-18.22M-12.12M-12.20M-11.67M6.30M-11.82M-12.79M-12.11M
Free Cash Flow -4.34M-2.43M0.54M-5.09M-8.36M-14.83M-2.15M-8.40M-7.94M-10.17M9.48M-11.93M-5.68M-19.98M-11.23M-19.45M-12.13M-12.20M-18.31M12.81M-14.91M-18.14M-10.73M
Net Cash Flow -4.34M-1.00M-0.89M11.39M113.45M87.48M-3.53M-20.15M-7.83M-10.45M9.87M-11.45M-3.99M-19.95M-11.18M-19.34M-11.63M-11.84M-17.85M13.64M-14.90M-18.14M-10.28M